Santaris Pharma A/S is an international clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies.

Utilizing its proprietary LNA Drug Platform and Drug Discovery Engine capabilities, Santaris Pharma A/S has created a robust pipeline of microRNA and mRNA targeted drugs for a range of diseases